Biomerica (BMRA) Interest & Investment Income (2010 - 2023)
Biomerica (BMRA) reported Interest & Investment Income of $55632.0 for Q2 2023, up 666.28% on a YoY basis from $7260.0 in Q2 2022, and up 54.17% sequentially from $36086.0 in Q1 2023.
Biomerica (BMRA) Interest & Investment Income (2010 - 2023) Analysis & Trends
Biomerica (BMRA) has 14 years of Interest & Investment Income data on file, last reported at $55632.0 in Q2 2023.
- For the quarter ending Q2 2023, Interest & Investment Income rose 666.28% year-over-year to $55632.0; the trailing twelve-month figure through May 2023 stood at $133000.0 (up 392.59% YoY), and the FY2023 full-year result was $133000.0, up 392.59% from the prior year.
- Interest & Investment Income rose to $55632.0 in Q2 2023, from $36086.0 in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $55632.0 in Q2 2023 to a low of $28.0 in Q3 2022.
- A 5-year average of $18349.1 and a median of $8037.0 in 2020 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income soared 7928.73% in 2019 and tumbled 99.59% in 2022, its largest moves.
- Tracing BMRA's Interest & Investment Income over 5 years: stood at $4488.0 in 2019, then jumped by 77.87% to $7983.0 in 2020, then decreased by 13.37% to $6916.0 in 2021, then jumped by 496.5% to $41254.0 in 2022, then surged by 34.85% to $55632.0 in 2023.
- Business Quant data shows BMRA's Interest & Investment Income at $55632.0 in Q2 2023, $36086.0 in Q1 2023, and $41254.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 106.00 Mn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 33.50 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 40.98 Mn |
| 10 | Biomerica | 4.88 Mn | 3.54 Mn | -44,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2023 | 55,632.00 |
| Feb 28, 2023 | 36,086.00 |
| Nov 30, 2022 | 41,254.00 |
| Aug 31, 2022 | 28.00 |
| May 31, 2022 | 7,260.00 |
| Feb 28, 2022 | 6,019.00 |
| Nov 30, 2021 | 6,916.00 |
| Aug 31, 2021 | 6,805.00 |
| May 31, 2021 | 13,102.00 |
| Feb 28, 2021 | 37,687.00 |
| Nov 30, 2020 | 7,983.00 |
| Aug 31, 2020 | 8,091.00 |
| May 31, 2020 | 8,678.00 |
| Feb 29, 2020 | 53,964.00 |
| Nov 30, 2019 | 4,488.00 |
| Aug 31, 2019 | 4,063.00 |
| May 31, 2019 | 3,726.00 |
| Feb 28, 2019 | 28,502.00 |
| Nov 30, 2018 | 8,693.00 |
| Aug 31, 2018 | 3,093.00 |